Evidence map›Paper›PMID 35974353›Full record

ArticleParasites & vectors2022

Fine-scale-mapping of Schistosoma haematobium infections at the school and community levels and intermediate host snail abundance in the north of Pemba Island: baseline cross-sectional survey findings before the onset of a 3-year intervention study.

Lydia Trippler, Said Mohammed Ali, Shaali Makame Ame, Jan Hattendorf, Khamis Rashid Suleiman, Mohammed Nassor Ali, Saleh Juma, Fatma Kabole, Stefanie Knopp

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Lydia TripplerDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Said Mohammed AliPublic Health Laboratory-Ivo de Carneri, Wawi Pemba, United Republic of Tanzania.
Shaali Makame AmePublic Health Laboratory-Ivo de Carneri, Wawi Pemba, United Republic of Tanzania.
Jan HattendorfDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Khamis Rashid SuleimanPublic Health Laboratory-Ivo de Carneri, Wawi Pemba, United Republic of Tanzania.
Mohammed Nassor AliPublic Health Laboratory-Ivo de Carneri, Wawi Pemba, United Republic of Tanzania.
Saleh JumaNeglected Diseases Program, Zanzibar Ministry of Health, Mkoroshoni, Pemba, United Republic of Tanzania.
Fatma KaboleNeglected Tropical Diseases Program Ministry of Health , Lumumba, Unguja, United Republic of Tanzania.
Stefanie KnoppDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland. s.knopp@swisstph.ch.
Public Health Laboratory Ivo de Carneri · TZUniversity of Basel · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PR00P3_179753 / 1
6 · The paper itself

Abstract

backgroundSchistosomiasis elimination has gained renewed priority in the WHO guidance documents published in 2020 and 2022. The SchistoBreak project, implemented in Pemba, Tanzania between 2020 and 2024, aims to assess new tools and strategies for shifting from elimination as a public health problem towards interruption of transmission. Here we report our baseline findings and discuss implications for future interventions.

methodsIn 2020, human water contact sites (HWCSs) in the study area were geolocated and snail surveys were conducted. A parasitological and questionnaire cross-sectional baseline survey was implemented in 20 communities and their 16 primary schools between November 2020 and February 2021. Urine samples were collected at the school and household levels from individuals aged ≥ 4 years. Schistosoma haematobium infection was detected by urine filtration microscopy. Snail, parasitological and questionnaire-derived data were analyzed descriptively, spatially and with generalized estimated equation models.

resultsThe intermediate host snail Bulinus globosus was detected in 19.8% (33/167) of HWCSs. The overall S. haematobium prevalence was 1.2% (26/2196) in school-aged children and 0.8% (31/3893) in community members, with 0.2% (4/2196) and 0.1% (3/3893) heavy-intensity infections, respectively. Children who studied < 1 km away from HWCSs with B. globosus had significantly higher odds for a S. haematobium infection than those attending a school located > 2 km away (odds ratio [OR]: 5.0; 95% confidence interval [CI]: 2.3-11.1). Individuals living in a house located < 1 km away from HWCSs with B. globosus had higher odds than those residing in > 2 km distance (OR: 18.0; 95% CI: 2.9-111.0). Self-reported praziquantel treatment coverage was 83.2% (2015/2423) in schoolchildren in the mass drug administration (MDA) conducted in August 2020. Coverage among adult community members was 59.9% (574/958), but only 34.8% (333/958) took praziquantel correctly.

conclusionsWhile the S. haematobium prevalence is very low in Pemba, there are many HWCSs with B. globosus situated close to schools or houses that pose a considerable risk of recrudescence. To maintain and accelerate the progress towards interruption of transmission, targeted and cost-effective interventions that are accepted by the community are needed; for example, snail control plus focal MDA, or test-and-treat in schools and households near infested waterbodies.

Indexed as

Schistosoma haematobiumSchistosomiasis haematobiaAdultAnimalsChildCross-Sectional StudiesHumansIndian Ocean IslandsPraziquantelPrevalenceSchoolsSnailsWaterPraziquantelWaterBulinus globosusDistanceEliminationFine-scale mappingFreshwater bodiesInterruption of transmissionMass drug administrationSchistosoma haematobiumSurveillance responseTest-and-treat

Identifiers

PMID35974353
PMCPMC9380971
OpenAlexW4292018534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.